comparemela.com

Latest Breaking News On - Bristol myers squibb reblozyl - Page 1 : comparemela.com

FDA approves Bristol Myers Squibb's Breyanzi for follicular lymphoma

The approval is based on results from the open-label, global, multicentre, single-arm Phase II TRANSCEND FL clinical trial.

Bristol-myers-squibb-breyanzi
Bryan-campbell
Bristol-myers-squibb-reblozyl
European-commission
Drug-administration
Bristol-myers-squibb
Myers-squibb
Pharmaceutical-technology

Expansion of Luspatercept Indication Underscores Evolving Treatment Landscape for Low-Risk MDS

Benjamin Tomlinson, MD, discusses the first-line approval of luspatercept and other ongoing research in low-risk MDS.

Cleveland
Ohio
United-states
Benjamin-tomlinson
Bristol-myers-squibb-reblozyl
Case-western-reserve-university-school-of-medicine
International-consensus-classification
Bristol-myers-squibb
World-health-organization
Cleveland-medical-center
University-hospitals
Science-summit

5 FDA decisions to watch in the second quarter

BioPharma

Germany
Canada
Canadian
Ned-pagliarulo
Ben-fidler
Bristol-myers-squibb-abecma
Delilah-alvarado
Bristol-myers-squibb-reblozyl
Regeneron-dupixent
Stephen-wiley
Jonathan-gardner
Johnson

Health: US FDA staff raises concerns on Geron's blood disorder drug

Health: US FDA staff raises concerns on Geron's blood disorder drug
gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.

United-states
John-scarlett
Robert-driscoll
Bristol-myers-squibb-reblozyl
Drug-administration
Reuters
Bristol-myers-squibb

Luspatercept Receives Positive EU CHMP Opinion for Treatment of Anemia in Lower-Risk MDS

Luspatercept has been recommended for approval by the EMA for patients with transfusion-dependent anemia and lower-risk myelodysplastic syndromes.

United-states
Bristol-myers-squibb-reblozyl
Anne-kerber
World-health-organization
European-commission
European-union
Bristol-myers-squibb
Head-of-late-clinical-development
International-prognostic-scoring-system
European-medicines-agency
Medicinal-products
Human-use

vimarsana © 2020. All Rights Reserved.